These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease. Mydock-McGrane LK; Hannan TJ; Janetka JW Expert Opin Drug Discov; 2017 Jul; 12(7):711-731. PubMed ID: 28506090 [TBL] [Abstract][Full Text] [Related]
7. The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease. Sivignon A; Bouckaert J; Bernard J; Gouin SG; Barnich N Expert Opin Ther Targets; 2017 Sep; 21(9):837-847. PubMed ID: 28762293 [TBL] [Abstract][Full Text] [Related]
9. Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin. Touaibia M; Krammer EM; Shiao TC; Yamakawa N; Wang Q; Glinschert A; Papadopoulos A; Mousavifar L; Maes E; Oscarson S; Vergoten G; Lensink MF; Roy R; Bouckaert J Molecules; 2017 Jul; 22(7):. PubMed ID: 28671638 [TBL] [Abstract][Full Text] [Related]
10. Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections. Mousavifar L; Touaibia M; Roy R Acc Chem Res; 2018 Nov; 51(11):2937-2948. PubMed ID: 30289687 [TBL] [Abstract][Full Text] [Related]
12. Heptyl α-D-mannosides grafted on a β-cyclodextrin core to interfere with Escherichia coli adhesion: an in vivo multivalent effect. Bouckaert J; Li Z; Xavier C; Almant M; Caveliers V; Lahoutte T; Weeks SD; Kovensky J; Gouin SG Chemistry; 2013 Jun; 19(24):7847-55. PubMed ID: 23595913 [TBL] [Abstract][Full Text] [Related]
13. Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI. Jarvis C; Han Z; Kalas V; Klein R; Pinkner JS; Ford B; Binkley J; Cusumano CK; Cusumano Z; Mydock-McGrane L; Hultgren SJ; Janetka JW ChemMedChem; 2016 Feb; 11(4):367-73. PubMed ID: 26812660 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists. Schwardt O; Rabbani S; Hartmann M; Abgottspon D; Wittwer M; Kleeb S; Zalewski A; Smieško M; Cutting B; Ernst B Bioorg Med Chem; 2011 Nov; 19(21):6454-73. PubMed ID: 21962988 [TBL] [Abstract][Full Text] [Related]
15. Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists. Schönemann W; Cramer J; Mühlethaler T; Fiege B; Silbermann M; Rabbani S; Dätwyler P; Zihlmann P; Jakob RP; Sager CP; Smieško M; Schwardt O; Maier T; Ernst B ChemMedChem; 2019 Apr; 14(7):749-757. PubMed ID: 30710416 [TBL] [Abstract][Full Text] [Related]
16. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Ratliff TL J Urol; 2005 Sep; 174(3):1150. PubMed ID: 16094085 [No Abstract] [Full Text] [Related]
17. FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile. Kleeb S; Pang L; Mayer K; Eris D; Sigl A; Preston RC; Zihlmann P; Sharpe T; Jakob RP; Abgottspon D; Hutter AS; Scharenberg M; Jiang X; Navarra G; Rabbani S; Smiesko M; Lüdin N; Bezençon J; Schwardt O; Maier T; Ernst B J Med Chem; 2015 Mar; 58(5):2221-39. PubMed ID: 25666045 [TBL] [Abstract][Full Text] [Related]
18. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Bouckaert J; Berglund J; Schembri M; De Genst E; Cools L; Wuhrer M; Hung CS; Pinkner J; Slättegård R; Zavialov A; Choudhury D; Langermann S; Hultgren SJ; Wyns L; Klemm P; Oscarson S; Knight SD; De Greve H Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162 [TBL] [Abstract][Full Text] [Related]
19. Structure-based drug design and optimization of mannoside bacterial FimH antagonists. Han Z; Pinkner JS; Ford B; Obermann R; Nolan W; Wildman SA; Hobbs D; Ellenberger T; Cusumano CK; Hultgren SJ; Janetka JW J Med Chem; 2010 Jun; 53(12):4779-92. PubMed ID: 20507142 [TBL] [Abstract][Full Text] [Related]
20. Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides. Han Z; Pinkner JS; Ford B; Chorell E; Crowley JM; Cusumano CK; Campbell S; Henderson JP; Hultgren SJ; Janetka JW J Med Chem; 2012 Apr; 55(8):3945-59. PubMed ID: 22449031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]